130 related articles for article (PubMed ID: 35885481)
1. Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma.
Rivas-Delgado A; Nadeu F; Andrade-Campos M; López C; Enjuanes A; Mozas P; Frigola G; Colomo L; Sanchez-Gonzalez B; Villamor N; Beà S; Campo E; Salar A; Giné E; López-Guillermo A; Bellosillo B
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885481
[TBL] [Abstract][Full Text] [Related]
2. Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.
Donzel M; Pesce F; Trecourt A; Groussel R; Bachy E; Ghesquières H; Fontaine J; Benzerdjeb N; Mauduit C; Traverse-Glehen A
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835560
[TBL] [Abstract][Full Text] [Related]
3. Low-Coverage Whole Genome Sequencing of Cell-Free DNA From Immunosuppressed Cancer Patients Enables Tumor Fraction Determination and Reveals Relevant Copy Number Alterations.
Bouzidi A; Labreche K; Baron M; Veyri M; Denis JA; Touat M; Sanson M; Davi F; Guillerm E; Jouannet S; Charlotte F; Bielle F; Choquet S; Boëlle PY; Cadranel J; Leblond V; Autran B; Lacorte JM; Spano JP; Coulet F;
Front Cell Dev Biol; 2021; 9():661272. PubMed ID: 34710202
[TBL] [Abstract][Full Text] [Related]
4. Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
Szymanski JJ; Sundby RT; Jones PA; Srihari D; Earland N; Harris PK; Feng W; Qaium F; Lei H; Roberts D; Landeau M; Bell J; Huang Y; Hoffman L; Spencer M; Spraker MB; Ding L; Widemann BC; Shern JF; Hirbe AC; Chaudhuri AA
PLoS Med; 2021 Aug; 18(8):e1003734. PubMed ID: 34464388
[TBL] [Abstract][Full Text] [Related]
5. Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket Study.
Smyth LM; Reichel JB; Tang J; Patel JAA; Meng F; Selcuklu DS; Houck-Loomis B; You D; Samoila A; Schiavon G; Li BT; Razavi P; Piscuoglio S; Reis-Filho JS; Taylor BS; Baselga J; Solit DB; Hyman DM; Berger MF; Chandarlapaty S
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250397
[TBL] [Abstract][Full Text] [Related]
6. Characterization of DLBCL with a PMBL gene expression signature.
Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.
Mottok A; Hung SS; Chavez EA; Woolcock B; Telenius A; Chong LC; Meissner B; Nakamura H; Rushton C; Viganò E; Sarkozy C; Gascoyne RD; Connors JM; Ben-Neriah S; Mungall A; Marra MA; Siebert R; Scott DW; Savage KJ; Steidl C
Blood; 2019 Sep; 134(10):802-813. PubMed ID: 31292115
[TBL] [Abstract][Full Text] [Related]
8. Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity.
Tuveri S; Debackere K; Marcelis L; Dierckxsens N; Demeulemeester J; Dimitriadou E; Dierickx D; Lefesvre P; Deraedt K; Graux C; Michaux L; Cools J; Tousseyn T; Vermeesch JR; Wlodarska I
Genes Chromosomes Cancer; 2022 Oct; 61(10):603-615. PubMed ID: 35611992
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study.
Camus V; Viennot M; Lévêque E; Viailly PJ; Tonnelet D; Veresezan EL; Drieux F; Etancelin P; Dubois S; Stamatoullas A; Tilly H; Bohers E; Jardin F
Leuk Lymphoma; 2022 Apr; 63(4):834-844. PubMed ID: 35075971
[TBL] [Abstract][Full Text] [Related]
10. Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study.
Rivas-Delgado A; Nadeu F; Enjuanes A; Casanueva-Eliceiry S; Mozas P; Magnano L; Castrejón de Anta N; Rovira J; Dlouhy I; Martín S; Osuna M; Rodríguez S; Simó M; Pinyol M; Baumann T; Beà S; Balagué O; Delgado J; Villamor N; Setoain X; Campo E; Giné E; López-Guillermo A
Clin Cancer Res; 2021 Jan; 27(2):513-521. PubMed ID: 33122345
[TBL] [Abstract][Full Text] [Related]
11. Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis.
Hatipoğlu T; Esmeray Sönmez E; Hu X; Yuan H; Danyeli AE; Şeyhanlı A; Önal-Süzek T; Zhang W; Akman B; Olgun A; Özkal S; Alacacıoğlu İ; Özcan MA; You H; Küçük C
Front Oncol; 2022; 12():870487. PubMed ID: 35795062
[TBL] [Abstract][Full Text] [Related]
12. Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort.
Chen X; Chang CW; Spoerke JM; Yoh KE; Kapoor V; Baudo C; Aimi J; Yu M; Liang-Chu MMY; Suttmann R; Huw LY; Gendreau S; Cummings C; Lackner MR
Clin Cancer Res; 2019 Apr; 25(7):2254-2263. PubMed ID: 30617129
[TBL] [Abstract][Full Text] [Related]
13. Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.
Hovelson DH; Liu CJ; Wang Y; Kang Q; Henderson J; Gursky A; Brockman S; Ramnath N; Krauss JC; Talpaz M; Kandarpa M; Chugh R; Tuck M; Herman K; Grasso CS; Quist MJ; Feng FY; Haakenson C; Langmore J; Kamberov E; Tesmer T; Husain H; Lonigro RJ; Robinson D; Smith DC; Alva AS; Hussain MH; Chinnaiyan AM; Tewari M; Mills RE; Morgan TM; Tomlins SA
Oncotarget; 2017 Oct; 8(52):89848-89866. PubMed ID: 29163793
[TBL] [Abstract][Full Text] [Related]
14. Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Gupta S; Hovelson DH; Kemeny G; Halabi S; Foo WC; Anand M; Somarelli JA; Tomlins SA; Antonarakis ES; Luo J; Dittamore RV; George DJ; Rothwell C; Nanus DM; Armstrong AJ; Gregory SG
Genes Chromosomes Cancer; 2020 Apr; 59(4):225-239. PubMed ID: 31705765
[TBL] [Abstract][Full Text] [Related]
15. Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines.
Dai H; Ehrentraut S; Nagel S; Eberth S; Pommerenke C; Dirks WG; Geffers R; Kalavalapalli S; Kaufmann M; Meyer C; Faehnrich S; Chen S; Drexler HG; MacLeod RA
PLoS One; 2015; 10(11):e0139663. PubMed ID: 26599546
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.
Chen BJ; Ruminy P; Roth CG; Bisig B; Mankel B; Steinhilber J; Bohers E; Jardin F; Fend F; Swerdlow SH; Copie-Bergman C; de Leval L; Quintanilla-Martinez L
Am J Surg Pathol; 2019 Jan; 43(1):110-120. PubMed ID: 30211726
[TBL] [Abstract][Full Text] [Related]
17. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.
Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A
Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953
[No Abstract] [Full Text] [Related]
18. The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Van Paemel R; Vandeputte C; Raman L; Van Thorre J; Willems L; Van Dorpe J; Van Der Linden M; De Wilde J; De Koker A; Menten B; Devalck C; Vicha A; Grega M; Schleiermacher G; Iddir Y; Chicard M; van Zogchel L; Stutterheim J; Lak NSM; Tytgat GAM; Laureys G; Speleman F; De Wilde B; Lammens T; De Preter K; Van Roy N
Eur J Cancer; 2022 Jan; 160():12-23. PubMed ID: 34794856
[TBL] [Abstract][Full Text] [Related]
19. Mutational landscape of gray zone lymphoma.
Sarkozy C; Hung SS; Chavez EA; Duns G; Takata K; Chong LC; Aoki T; Jiang A; Miyata-Takata T; Telenius A; Slack GW; Molina TJ; Ben-Neriah S; Farinha P; Dartigues P; Damotte D; Mottok A; Salles GA; Casasnovas RO; Savage KJ; Laurent C; Scott DW; Traverse-Glehen A; Steidl C
Blood; 2021 Apr; 137(13):1765-1776. PubMed ID: 32961552
[TBL] [Abstract][Full Text] [Related]
20. Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients.
Van Roy N; Van Der Linden M; Menten B; Dheedene A; Vandeputte C; Van Dorpe J; Laureys G; Renard M; Sante T; Lammens T; De Wilde B; Speleman F; De Preter K
Clin Cancer Res; 2017 Oct; 23(20):6305-6314. PubMed ID: 28710315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
